Efficacy of Delafloxacin versus Moxifloxacin against Bacterial Respiratory Pathogens in Adults with Community-Acquired Bacterial Pneumonia (CABP): Microbiology Results from the Delafloxacin Phase 3 CABP Trial델라플록사신과 모키플록사신의 성능: 지역사회 획득 세균성 폐렴(CABP) 성인에서 세균 호흡기 병원체에 대한 미생물학적 결과 - 델라플록사신 3상 CABP 시험Article Published on 2020-02-212024-07-31 Journal: Med Instrum [Category] 폐렴구균 감염증, [키워드] clinical trial community-acquired bacterial pneumonia Delafloxacin Fluoroquinolone [DOI] 10.1128/AAC.01949-19 PMC 바로가기
Antibacterial Activity of Lefamulin against Pathogens Most Commonly Causing Community-Acquired Bacterial Pneumonia: SENTRY Antimicrobial Surveillance Program (2015-2016)레파물린의 지역사회 획득 세균성 폐렴을 가장 흔히 유발하는 병원체에 대한 항균 활성: SENTRY 항균 감시 프로그램 (2015-2016)Article Published on 2019-03-272024-08-24 Journal: Med Instrum [Category] 폐렴구균 감염증, [키워드] antimicrobial community-acquired bacterial pneumonia lefamulin pleuromutilin.
Spotlight on solithromycin in the treatment of community-acquired bacterial pneumonia: design, development, and potential place in therapyarticle Published on 2017-12-312024-09-01 Journal: Drug Design, Development and Therapy [Category] 폐렴구균 감염증, [키워드] CABP community-acquired bacterial pneumonia Macrolide antibiotics solithromycin [Article Type] article